Kerusso Capital Management’s Pfizer PFE Stock Holding History

Kerusso Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.77M	Sell	73,697 -59,729	-45%	-$1.56M	0.65%	56
2026 Q1	$3.75M	Sell	133,426 -9,472	-7%	-$252K	1.88%	25
2025 Q4	$3.56M	Buy	142,898 +34,848	+32%	+$879K	1.64%	37
2025 Q3	$2.75M	Sell	108,050 -6,260	-5%	-$155K	1.69%	34
2025 Q2	$2.77M	Buy	114,310 +61	+0.1%	+$1.42K	1.71%	27
2025 Q1	$2.9M	Buy	114,249 +2,920	+3%	+$76.4K	1.84%	30
2024 Q4	$2.95M	Buy	111,329 +248	+0.2%	+$6.73K	1.89%	22
2024 Q3	$3.21M	Buy	111,081 +6,759	+6%	+$197K	2.04%	16
2024 Q2	$2.92M	Buy	+104,322	New	+$2.87M	2.12%	17

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Kerusso Capital Management's PFE Position: Q2 2026 in Review

Kerusso Capital Management reduced its Pfizer (PFE) stake by 45% in Q2 2026, selling an estimated $1.56M and leaving 73,697 shares worth $1.77M. The position accounts for 0.65% of the portfolio, ranked #56.

Kerusso Capital Management first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.75M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Kerusso Capital Management held 73,697 shares of Pfizer worth $1.77M as of Q2 2026.
Kerusso Capital Management sold 59,729 Pfizer shares in Q2 2026, an estimated $1.56M.
Pfizer made up 0.65% of Kerusso Capital Management's portfolio in Q2 2026, its #56 holding.
Kerusso Capital Management first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
Kerusso Capital Management's Pfizer position peaked at $3.75M in Q1 2026.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kerusso Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.